Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.

Details

Ressource 1Request a copy Sous embargo jusqu'au 24/01/2021.
State: Public
Version: Author's accepted manuscript
License: Not specified
Serval ID
serval:BIB_2D3D01CB1F02
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.
Journal
The international journal of cardiovascular imaging
Author(s)
van Heeswijk R.B., Bastiaansen JAM, Iglesias J.F., Degrauwe S., Rotman S., Barras J.L., Regamey J., Lauriers N., Tozzi P., Yerly J., Ginami G., Stuber M., Hullin R.
ISSN
1875-8312 (Electronic)
ISSN-L
1569-5794
Publication state
Published
Issued date
03/2020
Peer-reviewed
Oui
Volume
36
Number
3
Pages
533-542
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
In search of a non-invasive alternative detection of early-stage cardiac allograft vasculopathy (CAV), in this preliminary study we tested the hypothesis that interstitial fibrosis quantified with cardiac magnetic resonance (CMR) can serve as a biomarker for the detection of CAV. Late-stage CAV was detected with routine X-ray coronary angiography (XRCA), while a coronary intima-media thickness ratio (IMTR) > 1 on optical coherence tomography (OCT) was used to detect early-stage CAV. Interstitial fibrosis was quantified in the endomyocardial biopsy (EMB) and indirectly with CMR as the T <sub>1</sub> relaxation time and extracellular volume (ECV). CMR was performed within 48 h of a single invasive procedure with XRCA, OCT, and EMB procurement in stable HTx recipients (n = 27; age 54 ± 13 years, 5.4 ± 3.7 years post-transplant). XRCA-CAV and IMTR > 1 were present in 15% and 75% of study patients, respectively. The T <sub>1</sub> relaxation times and ECV were increased in patients with XRCA-CAV (p = 0.03 each), while IMTR and EMB interstitial fibrosis were not significantly different (both p > 0.05). ECV (ρ = 0.46, p = 0.02) and IMTR (ρ = 0.58; p = 0.01) correlated with the histological quantity of interstitial fibrosis, while the T <sub>1</sub> relaxation time (p = 0.06) did not. The correlation of the IMTR with the EMB interstitial fibrosis tentatively validates the hypothesis that interstitial fibrosis may serve as an early indicator of CAV. Moreover, the significant association of CMR-based ECV with the magnitude of interstitial fibrosis in the biopsy suggests ECV as a potential biomarker for interstitial fibrosis due to early-stage CAV. The measurement of ECV may therefore have a role for non-invasive detection and follow-up of early-stage CAV.
Keywords
Adult, Aged, Biopsy, Coronary Angiography, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/etiology, Coronary Artery Disease/pathology, Early Diagnosis, Female, Fibrosis, Heart Transplantation/adverse effects, Humans, Magnetic Resonance Imaging, Cine, Male, Middle Aged, Myocardium/pathology, Pilot Projects, Predictive Value of Tests, Proof of Concept Study, Tomography, Optical Coherence, Treatment Outcome, Ventricular Remodeling, Cardiac allograft vasculopathy, Cardiovascular magnetic resonance, Extracellular volume, Heart transplantation, Interstitial fibrosis, Optical coherence tomography
Pubmed
Web of science
Create date
18/11/2019 12:47
Last modification date
07/07/2020 5:20
Usage data